Bioethics News

Now There’s Proof: Docs Who Get Company Cash Tend to Prescribe More Brand-Name Meds

(Pro Publica) – Doctors have long disputed that the payments they receive from pharmaceutical companies have any relationship to how they prescribe drugs. There’s been little evidence to settle the matter — until now. A ProPublica analysis has found for the first time that doctors who receive payments from the medical industry do indeed tend to prescribe drugs differently than their colleagues who don’t. And the more money they receive, on average, the more brand-name medications they prescribe.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.